These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33667366)
21. Generation of Cancer-Specific Cytotoxic PD-1 Lu S; Yang N; He J; Gong W; Lai Z; Xie L; Tao L; Xu C; Wang H; Zhang G; Cao H; Zhou C; Zhong L; Zhao Y J Biomed Nanotechnol; 2019 Mar; 15(3):593-601. PubMed ID: 31165703 [TBL] [Abstract][Full Text] [Related]
22. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting. Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774 [TBL] [Abstract][Full Text] [Related]
23. CRISPR EATING on a Low Budget. Kaya-Okur HS; Belmont AS Dev Cell; 2015 Aug; 34(3):253-4. PubMed ID: 26267392 [TBL] [Abstract][Full Text] [Related]
28. E Pluribus Unum ("Out of Many, One"): CRISPR Modeling of Myeloid Expansion. Shin J; Corn JE Cell Stem Cell; 2017 Oct; 21(4):415-416. PubMed ID: 28985519 [TBL] [Abstract][Full Text] [Related]
29. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy. Zhang X; Cheng C; Sun W; Wang H Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414 [TBL] [Abstract][Full Text] [Related]
30. CRISPR-Based Tools in Immunity. Simeonov DR; Marson A Annu Rev Immunol; 2019 Apr; 37():571-597. PubMed ID: 30698999 [TBL] [Abstract][Full Text] [Related]
31. [The application of CRISPR/Cas9 genome editing technology in cancer research]. Wang DY; Ma N; Hui Y; Gao X Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518 [TBL] [Abstract][Full Text] [Related]
32. Short communication: Determination of Salmonella clustered regularly interspaced short palindromic repeats (CRISPR) diversity on dairy farms in Wisconsin and Minnesota. Wehnes CA; Rehberger TG; Barrangou R; Smith AH J Dairy Sci; 2014 Oct; 97(10):6370-7. PubMed ID: 25108866 [TBL] [Abstract][Full Text] [Related]
33. Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding. Drost J; Clevers H Mol Cell; 2016 Aug; 63(3):352-4. PubMed ID: 27494556 [TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591 [TBL] [Abstract][Full Text] [Related]
35. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy. Potts MA; McDonald JA; Sutherland KD; Herold MJ Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035 [TBL] [Abstract][Full Text] [Related]
36. Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells. Kampmann M Chem Commun (Camb); 2017 Jun; 53(53):7162-7167. PubMed ID: 28487920 [TBL] [Abstract][Full Text] [Related]
37. Engineered CRISPR Systems for Next Generation Gene Therapies. Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198 [TBL] [Abstract][Full Text] [Related]
38. 3D Spheroids Propel Tumor Characterization. Li S; Zhang Z; Han L Trends Cancer; 2020 Aug; 6(8):622-624. PubMed ID: 32423684 [TBL] [Abstract][Full Text] [Related]
39. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo. Codina A; Renauer PA; Wang G; Chow RD; Park JJ; Ye H; Zhang K; Dong MB; Gassaway B; Ye L; Errami Y; Shen L; Chang A; Jain D; Herbst RS; Bosenberg M; Rinehart J; Fan R; Chen S Cell Syst; 2019 Feb; 8(2):136-151.e7. PubMed ID: 30797773 [TBL] [Abstract][Full Text] [Related]
40. In vitro modeling of CD8 Wu JE; Manne S; Ngiow SF; Baxter AE; Huang H; Freilich E; Clark ML; Lee JH; Chen Z; Khan O; Staupe RP; Huang YJ; Shi J; Giles JR; Wherry EJ Sci Immunol; 2023 Aug; 8(86):eade3369. PubMed ID: 37595022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]